Here are five things to know about the telehealth company’s financial performance for the first quarter, which ended March 31.
1. Teladoc posted a 41 percent year-over-year increase in revenue in the first quarter at $180.8 million.
2. The company posted $43.7 million in visit revenue for the first quarter, up 93 percent from $22.6 million during the same time last year.
3. Teladoc’s net loss was $29.6 million for the first quarter compared to $30.2 million for the first quarter of 2019.
4. The company anticipates total revenue for the second quarter between $215 million and $225 million, with full-year 2020 revenue expected between $800 million and $825 million.
5. Teladoc expects total visits between 2.3 million and 2.4 million during the second quarter and between 8 million and 9 million for the full year.
More articles on telehealth:
Mayo physicians virtually join New York clinicians on COVID-19 patient rounds
‘The genie’s out of the bottle on this one’: Seema Verma hints at the future of telehealth for CMS beneficiaries
The 8 hospitals that have received the most funding from FCC’s COVID-19 telehealth program
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
